Chemical Structure (Rosuvastatin Aurobindo 1)
Rosuvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8533
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rosuvastatin Calcium (NDC 0615-8533). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1. Time To First Occurrence Of Major Cardiovascular Events In Jupiter (Rosuvastatin Aurobindo 2)
Figure 2. Major Cv Events By Treatment Group In Jupiter (Rosuvastatin Aurobindo 3)
The text provides evaluation results for a study comparing the effects of Roswa20mg and Placebo20mg on various cardiovascular events. It includes data on the number of events observed for the primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The hazard ratios with confidence intervals and p-values are also provided for each event. Additionally, the text explains that cardiovascular death includes fatal MI, fatal stroke, sudden death, and other adjudicated causes of CV death.*
Figure 3. (Rosuvastatin Aurobindo 4)
This text provides information on the percent change from baseline in LDL-C levels for different doses of four types of statin medications: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin. The doses presented for each medication are 10 mg, 20 mg, and 40 mg, except for Atorvastatin, which also includes a 80 mg dose.*
Principal Display Panel (Rosuvastatin Aurobindo 5)
This appears to be a detailed description of Rosuvastatin tablets in the dosage of 5 mg. The packaging information, manufacturer details, and storage instructions are provided. The text also mentions the composition of each tablet and advises on the storage temperature range. It also includes dosage information and the trademark associated with the package. Additionally, the text lists various lot numbers for the product and the corresponding manufacturers. Overall, this text provides insights into the information typically found on pharmaceutical packaging and labels.*
Principal Display Panel (Rosuvastatin Aurobindo 6)
This text appears to be a pharmaceutical label for Rosuvastatin tablets, USP 10mg, manufactured by Aurobindo and packaged by Vangard. It includes information on dosages, storage instructions (20-25°C), protective measures from moisture, and a notice that it is for institutional use only. The tablets contain rosuvastatin calcium USP equivalent to 10mg of rosuvastatin. The label also mentions Vangard Glasgow, KY 42141, as the packaging location.*
Principal Display Panel (Rosuvastatin Aurobindo 7)
This text appears to be a listing for Rosuvastatin tablets in 20 mg strength, with various lot numbers and manufacturing information. It includes dosage instructions, storage conditions, and the manufacturer's details. The tablets contain rosuvastatin calcium equivalent to 20 mg of rosuvastatin. There are guidelines on protecting the tablets from moisture and storing them within a specific temperature range. The text also mentions that the usual dosage information can be found in the package insert. The tablets are indicated for institutional use only.*
Principal Display Panel (Rosuvastatin Aurobindo 8)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
